Question of reimbursing breast prostheses brought up at EP (European Parliament)
This article was originally published in Clinica
Executive Summary
The question of whether European national health insurance schemes should reimburse the cost of breast prostheses for reconstructive surgery following breast cancer surgery has been raised at the European Parliament. The issue came up on June 5 during the debate preceding the adoption by the European Parliament has adopted of own-initiative report by German MEP Karin Jons. This report calls for the Commission and EU member states to make the battle against breast cancer a priority (see Clinica No 1056, p 3).
You may also be interested in...
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.